The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicitySheila Miknyoczki, Bruce Ruggeri, Jean Husten et al.|Molecular Cancer Therapeutics|2007Cited by 112
Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituentMichael R. Myers, Alfred P. Spada, Natalie N. Setzer et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 44
Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4<i>H</i>-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic AgentRobert L. Hudkins, Bruce Ruggeri, Mark A. Ator et al.|Journal of Medicinal Chemistry|2011Cited by 42